IP commercialisation firm Biofusion completes IPO
This article was originally published in Clinica
Executive Summary
Biofusion, the company formed to commercialise intellectual property originating in the University of Sheffield, UK, has raised £8.2m ($15.4m) in its initial public offering. It was due to float on London's Alternative Investment Market (AIM) on February 2.